neostigmine has been researched along with Carcinoma, Bronchial in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Panettiere, FJ | 1 |
| Williams, D | 1 |
1 review available for neostigmine and Carcinoma, Bronchial
| Article | Year |
|---|---|
The current management of malignancy. IV.-Cancer of the lung.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Adult; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, S | 1975 |
1 other study available for neostigmine and Carcinoma, Bronchial
| Article | Year |
|---|---|
The management of myasthenia.
Topics: Adult; Ambenonium Chloride; Carcinoma, Bronchogenic; Ephedrine; Female; Follow-Up Studies; Humans; H | 1967 |